BRCA2 and neoplasm: Similarly, there was no difference in survival between MF/MC or unifocal tumours in BRCA1 mutation carriers (Figure 2B) or BRCA2 mutation carriers (Figure 2C), nor was there a difference in all‐cause survival between women with unifocal versus MF/MC disease (Figure 2D).